Table 2 Quality variables for selected empirical studies that assess the impact of health care judicialization on equity
From: Is the judicialization of health care bad for equity? A scoping review
Variables | Objective | |
|---|---|---|
Equity | Equity approach | Whether the study takes a horizontal or a vertical approach to equity |
Procedural justice | Whether it incorporates procedural justice concerns | |
Quality | Fit | How good is the fit between the research question and the methodological design |
Generalizability | Whether the findings are generalizable to other cases | |
Data reliability | Whether the data used is reliable | |
Data representativity | Whether the data used is representative of the case | |
Replicability | Whether the study can be replicated (i.e. it has a clear methodological strategy and the data is available) | |
Intercoder reliability test | Whether it has an IRT protocol or not | |
Type of litigant indicators | Location | Whether it incorporates and elaborates on the litigants’ place of residence |
Litigants’ relationship with health system | Public, private, contributory, subsidized, etc. | |
Individual demographics | Age, education, income, etc. | |
Intermediaries | Whether the litigant was represented by Attorney, patients’ organization, NGO, public attorney, physician | |
Type of claim indicators | Health benefits package (HBP) | Whether the claim is included in the HBP or not |
Prices | How much the claim costs | |
Cost-effectiveness | Whether there is scientific evidence of the effectiveness of the treatment and/or whether it is cost-effective | |
Policy impacts | New policies | The creation of new public policies |
Effectiveness of current policies | The improvement of current policies | |
Symbolic impacts | Participation, deliberation, legitimacy, reframing | Whether judicialization of health care empowers, democratizes, etc. |